sentence1 stringlengths 1.08k 96.5k | sentence2 stringlengths 51 966 | labels stringclasses 3
values | metadata stringlengths 123 2.56k |
|---|---|---|---|
Background
The opioid sparing effect of low dose ketamine is influenced by bolus dose, infusion rate, duration of infusion, and differences in the intensity of postoperative pain. In this study, we investigated the opioid sparing effect of low dose ketamine in patients with intravenous patient-controlled analgesia (PC... | Intervention: ketamine infusion of 2 µg/kg/min following bolus 0.5 mg/kg
Comparator: saline infusion following bolus of saline or ketamine infusion of 1 µg/kg/min following bolus 0.5 mg/kg
Outcome: The patient satisfaction rate | 0 | {"evidence_spans": [{"end": 1528, "start": 1457, "text": "ts and patient satisfaction were not significantly different among the "}, {"end": 8595, "start": 8520, "text": "ble among the groups (Table 3). The patient satisfaction rate was similar a"}], "id": "13596", "pmcid": "3695250", "prompt_id": "13596", "split_group... |
Background
The opioid sparing effect of low dose ketamine is influenced by bolus dose, infusion rate, duration of infusion, and differences in the intensity of postoperative pain. In this study, we investigated the opioid sparing effect of low dose ketamine in patients with intravenous patient-controlled analgesia (PC... | Intervention: ketamine infusion of 2 µg/kg/min following bolus 0.5 mg/kg
Comparator: saline infusion following bolus of saline or ketamine infusion of 1 µg/kg/min following bolus 0.5 mg/kg
Outcome: The incidence of adverse events | 0 | {"evidence_spans": [{"end": 1528, "start": 1421, "text": "ement, the incidence of adverse events and patient satisfaction were not significantly different among the "}, {"end": 8519, "start": 8384, "text": "d bad dreams or hallucinations. The incidence of adverse events such as nausea, vomiting, dizziness, headache, an... |
OBJECTIVE
Attempts to build an artificial pancreas by using subcutaneous insulin delivery from a portable pump guided by an subcutaneous glucose sensor have encountered delays and variability of insulin absorption. We tested closed-loop intraperitoneal insulin infusion from an implanted pump driven by an subcutaneous ... | Intervention: Two-day closed-loop therapy (except for a 15-min premeal manual bolus)
Comparator: 1-day control phase with intraperitoneal open-loop insulin delivery
Outcome: percentage of time between 4.4 and 6.6 mmol/l | 1 | {"evidence_spans": [{"end": 1063, "start": 806, "text": "SULTS\r\nDuring the closed-loop phases, the mean \u00b1 SEM percentage of time spent with blood glucose in the 4.4\u20136.6 mmol/l range was significantly higher (39.1 \u00b1 4.5 vs. 27.7 \u00b1 6.2%, P = 0.05), and overall dispersion of blood glucose values was ... |
OBJECTIVE
Attempts to build an artificial pancreas by using subcutaneous insulin delivery from a portable pump guided by an subcutaneous glucose sensor have encountered delays and variability of insulin absorption. We tested closed-loop intraperitoneal insulin infusion from an implanted pump driven by an subcutaneous ... | Intervention: Two-day closed-loop therapy (except for a 15-min premeal manual bolus)
Comparator: 1-day control phase with intraperitoneal open-loop insulin delivery
Outcome: plasma insulin peak levels | -1 | {"evidence_spans": [{"end": 15477, "start": 15348, "text": " (6.2 \u00b1 0.4 vs. 7.9 \u00b1 0.9 mmol/l, P = 0.069). Data analysis in early postprandial periods showed similar glucose peak levels and "}, {"end": 15572, "start": 15348, "text": " (6.2 \u00b1 0.4 vs. 7.9 \u00b1 0.9 mmol/l, P = 0.069). Data analysis in earl... |
Aim:
To study the effects of infusion of atrial natriuretic peptide (ANP) versus the inhalation of nitric oxide (NO) in patients with an early acute respiratory distress syndrome (ARDS).
Methods:
Ten patients with severe ARDS were studied in a crossover study design, within 72 hours after starting mechanical venti... | Intervention: inhalation of nitric oxide (NO) (20 ppm for 1 hour)
Comparator: atrial natriuretic peptide (ANP) infusion (10 ng/kg/min for 1 hour)
Outcome: mean pulmonary artery pressure, pulmonary vascular resistance index and central venous pressure | -1 | {"evidence_spans": [{"end": 1175, "start": 606, "text": "ults:\r\nDespite an approximate 50% increase in mixed venous ANP plasma concentration (from 86 \u00b1 21 to 123 \u00b1 33 ng/l, P < 0.05) during ANP infusion, there were no changes in mean pulmonary artery pressure, pulmonary vascular resistance index, extravascu... |
Background
The aim of this pilot study was to examine the effects of additional resistance training after use of Botulinum Toxin-A (BoNT-A) on the upper limbs in children with cerebral palsy (CP).
Methods
Ten children with CP (9–17 years) with unilaterally affected upper limbs according to Manual Ability Classific... | Intervention: Botulinum Toxin-A (BoNT-A) treatment (B)
Comparator: BoNT-A plus eight weeks resistance training (BT)
Outcome: improvements in AHA and Melbourne | 0 | {"evidence_spans": [{"end": 1126, "start": 994, "text": "sults\r\nBoth groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between "}], "id": "13607", "pmcid": "3511174", "prompt_id": "13607", "split_group_id": "3511174", "votes": {"0": 2}} |
Background
The aim of this pilot study was to examine the effects of additional resistance training after use of Botulinum Toxin-A (BoNT-A) on the upper limbs in children with cerebral palsy (CP).
Methods
Ten children with CP (9–17 years) with unilaterally affected upper limbs according to Manual Ability Classific... | Intervention: Botulinum Toxin-A (BoNT-A) treatment (B)
Comparator: BoNT-A plus eight weeks resistance training (BT)
Outcome: The muscle tone | 0 | {"evidence_spans": [{"end": 20626, "start": 20302, "text": "as circles. Significant group differences in treatment effect are indicated.\r\nThe muscle tone results, measured as resistance to passive elbow extension and forearm supination, are shown in Figure 3. In both groups there was only a small, non-significant dec... |
Background
The aim of this pilot study was to examine the effects of additional resistance training after use of Botulinum Toxin-A (BoNT-A) on the upper limbs in children with cerebral palsy (CP).
Methods
Ten children with CP (9–17 years) with unilaterally affected upper limbs according to Manual Ability Classific... | Intervention: Botulinum Toxin-A (BoNT-A) treatment (B)
Comparator: BoNT-A plus eight weeks resistance training (BT)
Outcome: Forearm supination resistance | 1 | {"evidence_spans": [{"end": 17298, "start": 17161, "text": "ne participant in group BT dropped out of the Post 5 months assessment.\r\nAt Baseline, the only significant group difference was higher fo"}], "id": "13609", "pmcid": "3511174", "prompt_id": "13609", "split_group_id": "3511174", "votes": {"1": 1}} |
Background
The aim of this pilot study was to examine the effects of additional resistance training after use of Botulinum Toxin-A (BoNT-A) on the upper limbs in children with cerebral palsy (CP).
Methods
Ten children with CP (9–17 years) with unilaterally affected upper limbs according to Manual Ability Classific... | Intervention: Botulinum Toxin-A (BoNT-A) treatment (B)
Comparator: BoNT-A plus eight weeks resistance training (BT)
Outcome: muscle strength in injected muscles nd non-injected muscles | 0 | {"evidence_spans": [{"end": 1428, "start": 1127, "text": "roups. There were significant, or close to significant, short-term treatment effects in favour of group BT for muscle strength in injected muscles (elbow flexion strength, p\u2009=\u2009.08) and non-injected muscles (elbow extension and supination strength, both... |
Background
Obesity has become a great problem all over the world. We repeatedly screened to find an effective food to treat obesity and discovered that rosehip extract shows potent anti-obesity effects. Investigations in mice have demonstrated that rosehip extract inhibits body weight gain and decreases visceral fat. ... | Intervention: 100 mg of rosehip extract
Comparator: placebo
Outcome: body weight and BMI | -1 | {"evidence_spans": [{"end": 1259, "start": 917, "text": "sults\r\nAbdominal total fat area, abdominal visceral fat area, body weight, and body mass index decreased significantly in the rosehip group at week 12 compared with their baseline levels (P<0.01) after receiving the rosehip tablet intake, and the decreases in t... |
Background
Obesity has become a great problem all over the world. We repeatedly screened to find an effective food to treat obesity and discovered that rosehip extract shows potent anti-obesity effects. Investigations in mice have demonstrated that rosehip extract inhibits body weight gain and decreases visceral fat. ... | Intervention: 100 mg of rosehip extract
Comparator: placebo
Outcome: the abdominal total fat area | -1 | {"evidence_spans": [{"end": 1259, "start": 917, "text": "sults\r\nAbdominal total fat area, abdominal visceral fat area, body weight, and body mass index decreased significantly in the rosehip group at week 12 compared with their baseline levels (P<0.01) after receiving the rosehip tablet intake, and the decreases in t... |
Background
Adequate muscle relaxation is important for ensuring optimal conditions for intubation. Although acceleromyography of the adductor pollicis muscle is commonly used to assess conditions for intubation, we hypothesized that acceleromyography of the trapezius is more indicative of optimal intubating conditions... | Intervention: endotracheal intubation after onset of the neuromuscular block at the adductor pollicis muscle (A)
Comparator: endotracheal intubation after onset at the trapezius muscle (B)
Outcome: time to maximum block | 1 | {"evidence_spans": [{"end": 14301, "start": 14089, "text": "ps with 49.2\u00a0\u00b1\u00a011.6\u00a0mA in group A, and 49.8\u00a0\u00b1\u00a011.6\u00a0mA in group T, respectively (mean\u00a0\u00b1\u00a0SD).\r\nFollowing injection of rocuronium, maximum block was recorded slightly later at the adductor pollicis muscle c... |
Background
Dyspnea, or shortness of breath, is a common symptom in patients with advanced cancer. Pharmacologic management is of proven benefit, but it does not help all patients. Preliminary data suggest that acupuncture can relieve dyspnea in a variety of populations, including cancer patients. We conducted a pilot ... | Intervention: receive a single session of true acupuncture
Comparator: receive a single session of placebo acupuncture
Outcome: score at follow-up | 0 | {"evidence_spans": [{"end": 1561, "start": 1279, "text": "p data. Dyspnea scores were slightly higher for patients receiving true versus placebo acupuncture, for both the period immediately following acupuncture treatment and for the daily one week follow-up (differences between means of 0.34, 95% C.I. -0.33, 1.02 and ... |
Background
Dyspnea, or shortness of breath, is a common symptom in patients with advanced cancer. Pharmacologic management is of proven benefit, but it does not help all patients. Preliminary data suggest that acupuncture can relieve dyspnea in a variety of populations, including cancer patients. We conducted a pilot ... | Intervention: receive a single session of true acupuncture
Comparator: receive a single session of placebo acupuncture
Outcome: Breathlessness | 0 | {"evidence_spans": [{"end": 20566, "start": 20336, "text": "nea. Hence we also provide a sub-group analysis of the immediate post-treatment scores, excluding patients scoring a mean of 2 or below. For all analyses, patients receiving true acupuncture reported slightly higher scores at foll"}, {"end": 22255, "start": 22... |
Background
Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).
Methods
In a randomized controlled study in adults, we compared treatment with esomeprazole 40 mg ... | Intervention: esomeprazole 40 mg twice daily
Comparator: placebo
Outcome: time to first pulmonary exacerbation | 0 | {"evidence_spans": [{"end": 892, "start": 789, "text": "study. There was no significant difference in time to first pulmonary exacerbation (log rank test p\u2009=\u20090"}, {"end": 12017, "start": 11859, "text": "group experienced exacerbations (esomeprazole vs. placebo: odds ratio\u2009=\u20093.455, 95% CI\u2009=\u200... |
Background
Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).
Methods
In a randomized controlled study in adults, we compared treatment with esomeprazole 40 mg ... | Intervention: esomeprazole 40 mg twice daily
Comparator: placebo
Outcome: exacerbation rate | 0 | {"evidence_spans": [{"end": 12300, "start": 12018, "text": "ulmonary exacerbation between the esomeprazole and placebo groups (log rank test p\u2009=\u20090.3169) (Figure\u00a02). Similarly, there was no significant difference between groups in exacerbation rate during the study period (2.04 exacerbations per person ye... |
Background
Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).
Methods
In a randomized controlled study in adults, we compared treatment with esomeprazole 40 mg ... | Intervention: esomeprazole 40 mg twice daily
Comparator: placebo
Outcome: change in FEV1 percent or FVC percent | 0 | {"evidence_spans": [{"end": 12583, "start": 12301, "text": " 4.14) compared with 0.59 exacerbations per person year in placebo group (95% CI (0.19, 1.82), p\u2009=\u20090.07. There was no significant change in FEV1 percent predicted or FVC percent predicted in either group over the study period, p\u2009=\u20090.23 and ... |
Background
Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).
Methods
In a randomized controlled study in adults, we compared treatment with esomeprazole 40 mg ... | Intervention: esomeprazole 40 mg twice daily
Comparator: placebo
Outcome: GSAS and CFQ-R score | 0 | {"evidence_spans": [{"end": 1294, "start": 1128, "text": ".334). There was no change in Forced Expiratory Volume in one second, Gastroesophageal Symptom Assessment Score or CF Quality of Life score between the two treatment "}, {"end": 12771, "start": 12584, "text": "ence between groups in change in FEV1 or FVC percent... |
Purpose
To evaluate the efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis (nr-axSpA).
Methods
Patients fulfilled Assessment of Spondyloarthritis international Society (ASAS) criteria for axial spondyloarthritis, had a Bath Ankylosing Spondylitis Disease Activity Index (BAS... | Intervention: adalimumab
Comparator: placebo
Outcome: percentage of nr-axSpA patients achieved the primary endpoint of ASAS40 response at week 12 | 1 | {"evidence_spans": [{"end": 1114, "start": 969, "text": "sults\r\nSignificantly more patients in the adalimumab group achieved ASAS40 at week 12 compared with patients in the placebo group (36% vs 15%, p<"}, {"end": 17803, "start": 17568, "text": "pA criteria (table 1). However, more patients who fulfilled the clinical... |
Purpose
To evaluate the efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis (nr-axSpA).
Methods
Patients fulfilled Assessment of Spondyloarthritis international Society (ASAS) criteria for axial spondyloarthritis, had a Bath Ankylosing Spondylitis Disease Activity Index (BAS... | Intervention: adalimumab
Comparator: placebo
Outcome: number of patients who had BASFI <2 at week 12 | 1 | {"evidence_spans": [{"end": 22096, "start": 21858, "text": "lacebo (table 2). In particular, there were significant decreases in each of the individual components of the ASAS40 response criteria except for BASFI. Although there was a numerically greater improvement in BASFI with adalimumab than wi"}], "id": "13633", "p... |
Introduction
Introduction:
Currently, using various combinations of sedative and analgesic agents has received attention for induction of sedation and analgesia due to their synergy in controlling pain and anxiety. The present study was designed with the aim of comparing dexmedetomidine-fentanyl combination with mida... | Intervention: the combination of fentanyl-midazolam
Comparator: dexmedetomidine-fentanyl
Outcome: treatment failure | -1 | {"evidence_spans": [{"end": 10671, "start": 10508, "text": "points decrease in pain score after receiving the drug. Out of the 9 patients who experienced treatment failure, 8 (88.90%) patients were in dexmedetomidine group "}, {"end": 10671, "start": 10510, "text": "ints decrease in pain score after receiving the drug.... |
Introduction
Introduction:
Currently, using various combinations of sedative and analgesic agents has received attention for induction of sedation and analgesia due to their synergy in controlling pain and anxiety. The present study was designed with the aim of comparing dexmedetomidine-fentanyl combination with mida... | Intervention: the combination of fentanyl-midazolam
Comparator: dexmedetomidine-fentanyl
Outcome: time to recovery | 1 | {"evidence_spans": [{"end": 11022, "start": 10943, "text": " the 2 groups from a clinical point of view; however, dexmedetomidine group had"}], "id": "13638", "pmcid": "5827042", "prompt_id": "13638", "split_group_id": "5827042", "votes": {"1": 1}} |
Background
Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intravenous (IV) supplementation in re-establishing iron stores. The purpose of this study was to determine if oral Heme Iron Pol... | Intervention: 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day
Comparator: IV iron sucrose 200 mg monthly
Outcome: hemoglobin | 0 | {"evidence_spans": [{"end": 1094, "start": 1015, "text": "tment, Hb in the HIP group was 117\u2009g/L and 113\u2009g/L in the IV sucrose group (p\u2009="}, {"end": 10983, "start": 10852, "text": " increases in the Hb, TSAT and serum ferritin in both the groups compared to their baseline values (Table\u20092). There was... |
Background
Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intravenous (IV) supplementation in re-establishing iron stores. The purpose of this study was to determine if oral Heme Iron Pol... | Intervention: 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day
Comparator: IV iron sucrose 200 mg monthly
Outcome: TSAT | 0 | {"evidence_spans": [{"end": 1167, "start": 1095, "text": "0.37). The TSAT at 6\u2009months was not different between the two groups {p\u2009"}, {"end": 11125, "start": 10984, "text": "e in the Hb in the HIP group was 117\u2009g/L and 113\u2009g/L in the IV sucrose group at 6\u2009months (p\u2009=\u20090.37; Table\u2009... |
Background
Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intravenous (IV) supplementation in re-establishing iron stores. The purpose of this study was to determine if oral Heme Iron Pol... | Intervention: 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day
Comparator: IV iron sucrose 200 mg monthly
Outcome: serum ferritin | -1 | {"evidence_spans": [{"end": 1287, "start": 1171, "text": "82}but the serum ferritin was significantly higher in the IV iron sucrose group {85.5 ug/L in HIP and 244 ug/L; p\u2009=\u2009"}, {"end": 11287, "start": 11125, "text": " 6\u2009months was also similar in both the groups {21.5%(17\u201329) in HIP and 21.5% (17\u... |
Background
Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intravenous (IV) supplementation in re-establishing iron stores. The purpose of this study was to determine if oral Heme Iron Pol... | Intervention: 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day
Comparator: IV iron sucrose 200 mg monthly
Outcome: adverse effects | 0 | {"evidence_spans": [{"end": 1349, "start": 1288, "text": ".004}. Overall adverse events were not different between the "}, {"end": 12734, "start": 12664, "text": "ne had surgery requiring withdraw from the study. In HIP group, one pa"}], "id": "13642", "pmcid": "3606612", "prompt_id": "13642", "split_group_id": "360661... |
A European placebo-controlled trial of antibiotic treatment for lower respiratory tract infection (LRTI) conducted in 16 primary care practices networks recruited participants between November 2007 and April 2010, and found adverse events (AEs) occurred more often in patients prescribed amoxicillin compared to placebo.... | Intervention: amoxicillin
Comparator: placebo
Outcome: proportion of any AE | 1 | {"evidence_spans": [{"end": 4538, "start": 4320, "text": "se Events\r\nFor the whole cohort, at the end of week one, a significantly higher proportion of any AE (diarrhoea or nausea or rash) was reported in the amoxicillin group compared to placebo (OR = 1.31, 95% CI 1.05\u20131.64)"}, {"end": 4526, "start": 4365, "tex... |
A European placebo-controlled trial of antibiotic treatment for lower respiratory tract infection (LRTI) conducted in 16 primary care practices networks recruited participants between November 2007 and April 2010, and found adverse events (AEs) occurred more often in patients prescribed amoxicillin compared to placebo.... | Intervention: amoxicillin
Comparator: placebo
Outcome: diarrhoea | 1 | {"evidence_spans": [{"end": 927, "start": 654, "text": " A significantly higher proportion of any AEs (diarrhoea or nausea or rash) (OR = 1.31, 95% CI 1.05\u20131.64, number needed to harm (NNH) = 24) and of diarrhoea (OR 1.43 95% CI 1.08\u20131.90, NNH = 29) was reported in the amoxicillin group during the first week ... |
A European placebo-controlled trial of antibiotic treatment for lower respiratory tract infection (LRTI) conducted in 16 primary care practices networks recruited participants between November 2007 and April 2010, and found adverse events (AEs) occurred more often in patients prescribed amoxicillin compared to placebo.... | Intervention: amoxicillin
Comparator: placebo
Outcome: Nausea | 0 | {"evidence_spans": [{"end": 6112, "start": 5993, "text": "ignificant.\r\nNausea was not associated with amoxicillin treatment for either the whole cohort or any subgroup of patien"}], "id": "13645", "pmcid": "5745479", "prompt_id": "13645", "split_group_id": "5745479", "votes": {"0": 1}} |
A European placebo-controlled trial of antibiotic treatment for lower respiratory tract infection (LRTI) conducted in 16 primary care practices networks recruited participants between November 2007 and April 2010, and found adverse events (AEs) occurred more often in patients prescribed amoxicillin compared to placebo.... | Intervention: amoxicillin
Comparator: placebo
Outcome: rash in males | 1 | {"evidence_spans": [{"end": 1122, "start": 929, "text": "Subgroup analysis showed rash was significantly more often reported in males prescribed amoxicillin (interaction term 3.72 95% CI 1.22\u201311.36; OR of amoxicillin in males 2.79 (95% CI 1.08\u20137.22)."}, {"end": 6259, "start": 6113, "text": "s (Table 3). Rash ... |
Background:
Iron supplementation is a chief component in prenatal care, with the aim of preventing anemia; however, extreme maternal iron status may adversely affect the birth outcome. Given the negative consequences of high maternal iron concentrations on pregnancy outcomes, it seems that iron supplementation in wome... | Intervention: one ferrous sulfate tablet containing 50 mg of elemental iron daily
Comparator: placebo
Outcome: The mean Hb concentration | 1 | {"evidence_spans": [{"end": 9326, "start": 9185, "text": "nd compared after delivery. The mean Hb concentration was 12.05 \u00b1 0.9 in the experimental and 11.94 \u00b1 0.6 in the placebo group; this differen"}], "id": "13647", "pmcid": "4753023", "prompt_id": "13647", "split_group_id": "4753023", "votes": {"1": 2}} |
Background:
Iron supplementation is a chief component in prenatal care, with the aim of preventing anemia; however, extreme maternal iron status may adversely affect the birth outcome. Given the negative consequences of high maternal iron concentrations on pregnancy outcomes, it seems that iron supplementation in wome... | Intervention: one ferrous sulfate tablet containing 50 mg of elemental iron daily
Comparator: placebo
Outcome: the mean of birth weight | 0 | {"evidence_spans": [{"end": 1506, "start": 1346, "text": " addition, the mean of birth weight in experimental group and control group were 3391/56 \u00b1 422, 3314/06 \u00b1 341, respectively and it was not significant differenc"}, {"end": 9434, "start": 9327, "text": " was significant (P = 0.03) but there was not sign... |
Background:
Iron supplementation is a chief component in prenatal care, with the aim of preventing anemia; however, extreme maternal iron status may adversely affect the birth outcome. Given the negative consequences of high maternal iron concentrations on pregnancy outcomes, it seems that iron supplementation in wome... | Intervention: one ferrous sulfate tablet containing 50 mg of elemental iron daily
Comparator: placebo
Outcome: ferritin | 1 | {"evidence_spans": [{"end": 1333, "start": 1108, "text": "Results:\r\nThere were statistically significant differences between the two groups in Hb (p = 0/03) and ferritin (p = 0/04) levels at the end of pregnancy, but the incidence of anemia exhibited no difference in either group (p"}, {"end": 10805, "start": 10755, ... |
Objective: We investigated the effect of the intraoperative use of a high dose remifentanil on insulin resistance and muscle protein catabolism.
Design: Randomized controlled study.
Patients and Intervention: Thirty-seven patients undergoing elective gastrectomy were randomly assigned to 2 groups that received remife... | Intervention: remifentanil at infusion rates of 0.1 μg·kg-1·min-1 (L)
Comparator: remifentanil at infusion rates of 0.5 μg·kg-1·min-1 (H)
Outcome: HOMA-IR before induction of anaesthesia, 60 min after the start of surgery, and at the start of skin closure | 0 | {"evidence_spans": [{"end": 12818, "start": 12627, "text": " the HOMA-IR and HOMA-\u03b2 measurements. HOMA-IR varied within normal limits before induction of anaesthesia, 60 min after the start of surgery, and at the start of skin closure, with no signifi"}], "id": "13650", "pmcid": "3714385", "prompt_id": "13650", "s... |
Objective: We investigated the effect of the intraoperative use of a high dose remifentanil on insulin resistance and muscle protein catabolism.
Design: Randomized controlled study.
Patients and Intervention: Thirty-seven patients undergoing elective gastrectomy were randomly assigned to 2 groups that received remife... | Intervention: remifentanil at infusion rates of 0.1 μg·kg-1·min-1 (L)
Comparator: remifentanil at infusion rates of 0.5 μg·kg-1·min-1 (H)
Outcome: HOMA-β values at 60 min after the start of surgery and skin closure | 0 | {"evidence_spans": [{"end": 13169, "start": 13003, "text": "r in the Group L than in the Group H. HOMA-\u03b2 values at 60 min after the start of surgery and skin closure were significantly lower in Group L than in the Group H, but"}], "id": "13651", "pmcid": "3714385", "prompt_id": "13651", "split_group_id": "3714385"... |
Objective: We investigated the effect of the intraoperative use of a high dose remifentanil on insulin resistance and muscle protein catabolism.
Design: Randomized controlled study.
Patients and Intervention: Thirty-seven patients undergoing elective gastrectomy were randomly assigned to 2 groups that received remife... | Intervention: remifentanil at infusion rates of 0.1 μg·kg-1·min-1 (L)
Comparator: remifentanil at infusion rates of 0.5 μg·kg-1·min-1 (H)
Outcome: 3-MH/Cr values | 0 | {"evidence_spans": [{"end": 1148, "start": 1049, "text": " L. There were no significant differences in the 3-MH/Cr values between the 2 groups at any time po"}], "id": "13652", "pmcid": "3714385", "prompt_id": "13652", "split_group_id": "3714385", "votes": {"0": 2}} |
Purpose
To compare the clinical outcomes of bone-patellar tendon-bone (BTB) allografts processed via a novel sterilization system with the traditional aseptically processed BTB allografts for anterior cruciate ligament (ACL) reconstruction.
Methods
A total of 67 patients undergoing ACL reconstruction at 6 independ... | Intervention: aseptic bone-patellar tendon-bone (BTB) allografts
Comparator: BioCleanse-sterilized allografts
Outcome: IKDC or KT-1000 results | 0 | {"evidence_spans": [{"end": 1231, "start": 997, "text": "rafts. Significant improvement in IKDC scores (P\u00a0<\u00a00.0001) as well as KT-1000 results (P\u00a0<\u00a00.0001) was noted over the 24-month period for both groups. IKDC or KT-1000 results were not significantly different between groups at any time"}, {"end... |
Purpose
To compare the clinical outcomes of bone-patellar tendon-bone (BTB) allografts processed via a novel sterilization system with the traditional aseptically processed BTB allografts for anterior cruciate ligament (ACL) reconstruction.
Methods
A total of 67 patients undergoing ACL reconstruction at 6 independ... | Intervention: aseptic bone-patellar tendon-bone (BTB) allografts
Comparator: BioCleanse-sterilized allografts
Outcome: Active flexion ROM | 0 | {"evidence_spans": [{"end": 1373, "start": 1232, "text": "point. Active flexion ROM significantly improved from pre-op to 24-month follow-up (P\u00a0<\u00a00.0001) with no difference between groups at any time"}], "id": "13654", "pmcid": "3751503", "prompt_id": "13654", "split_group_id": "3751503", "votes": {"0": 2}} |
Purpose
To compare the clinical outcomes of bone-patellar tendon-bone (BTB) allografts processed via a novel sterilization system with the traditional aseptically processed BTB allografts for anterior cruciate ligament (ACL) reconstruction.
Methods
A total of 67 patients undergoing ACL reconstruction at 6 independ... | Intervention: aseptic bone-patellar tendon-bone (BTB) allografts
Comparator: BioCleanse-sterilized allografts
Outcome: Active extension ROM | 0 | {"evidence_spans": [{"end": 1447, "start": 1374, "text": "point. Active extension ROM did not differ significantly between the two "}], "id": "13655", "pmcid": "3751503", "prompt_id": "13655", "split_group_id": "3751503", "votes": {"0": 2}} |
Abstract
Background:
Atorvastatin decreases blood lipids but is associated with side effects. Zhibitai is a traditional Chinese medicine used to treat blood lipid disorders. The objective of this study is to evaluate the lipid-lowering effect, antiinflammatory effect, and adverse events of zhibitai combined to atorva... | Intervention: zhibitai 480 mg + atorvastatin 10 mg (ZA10 group)
Comparator: atorvastatin 20 mg (A20 group) or atorvastatin 40 mg (A40 group)
Outcome: triglycerides | 0 | {"evidence_spans": [{"end": 1070, "start": 794, "text": " 8 weeks, triglycerides, total cholesterol (TC), LDL-cholesterol (LDL-C), and apolipoprotein B100 (ApoB100) levels were decreased in the ZA10 group (\u221264%, \u221237%, \u221246%, and \u221254%, respectively, compared with baseline), and these changes were simi... |
Abstract
Background:
Atorvastatin decreases blood lipids but is associated with side effects. Zhibitai is a traditional Chinese medicine used to treat blood lipid disorders. The objective of this study is to evaluate the lipid-lowering effect, antiinflammatory effect, and adverse events of zhibitai combined to atorva... | Intervention: zhibitai 480 mg + atorvastatin 10 mg (ZA10 group)
Comparator: atorvastatin 20 mg (A20 group) or atorvastatin 40 mg (A40 group)
Outcome: cardiotrophin-1 (CT-1) and high sensitivity-C reactive protein (hs-CRP) | 0 | {"evidence_spans": [{"end": 1312, "start": 1071, "text": "\u200a0.05). CT-1 and high sensitivity-C reactive protein (hs-CRP) levels were significantly decreased in the ZA10 group after 4 and 8 weeks (4 weeks: \u221273% and 96%; 8 weeks: \u221289% and \u221298%; all P\u200a<\u200a0.01), without differences among the 3 g... |
Abstract
Background:
Atorvastatin decreases blood lipids but is associated with side effects. Zhibitai is a traditional Chinese medicine used to treat blood lipid disorders. The objective of this study is to evaluate the lipid-lowering effect, antiinflammatory effect, and adverse events of zhibitai combined to atorva... | Intervention: zhibitai 480 mg + atorvastatin 10 mg (ZA10 group)
Comparator: atorvastatin 20 mg (A20 group) or atorvastatin 40 mg (A40 group)
Outcome: creatine kinase | 0 | {"evidence_spans": [{"end": 12555, "start": 12451, "text": "o significant difference can be observed (P\u200a>\u200a0.05), There was no significant difference in CK between t"}], "id": "13658", "pmcid": "5319516", "prompt_id": "13658", "split_group_id": "5319516", "votes": {"0": 2}} |
In the Belatacept Evaluation of Nephroprotection and Efficacy as First‐Line Immunosuppression Trial–Extended Criteria Donors (BENEFIT‐EXT), extended criteria donor kidney recipients were randomized to receive belatacept‐based (more intense [MI] or less intense [LI]) or cyclosporine‐based immunosuppression. In prior ana... | Intervention: belatacept (more intense [MI] or less intense [LI])
Comparator: cyclosporine
Outcome: time to death or graft loss | 0 | {"evidence_spans": [{"end": 961, "start": 722, "text": "Hazard ratios (HRs) comparing time to death or graft loss were 0.915 (95% confidence interval [CI] 0.625\u20131.339; p = 0.65) for belatacept MI versus cyclosporine and 0.927 (95% CI 0.634\u20131.356; p = 0.70) for belatacept LI versus cyclosporine."}], "id": "136... |
In the Belatacept Evaluation of Nephroprotection and Efficacy as First‐Line Immunosuppression Trial–Extended Criteria Donors (BENEFIT‐EXT), extended criteria donor kidney recipients were randomized to receive belatacept‐based (more intense [MI] or less intense [LI]) or cyclosporine‐based immunosuppression. In prior ana... | Intervention: belatacept (more intense [MI] or less intense [LI])
Comparator: cyclosporine
Outcome: Mean estimated GFR (eGFR) | 1 | {"evidence_spans": [{"end": 1164, "start": 962, "text": "Mean estimated GFR (eGFR) plus or minus standard error at 7 years was 53.9 \u00b1 1.9, 54.2 \u00b1 1.9, and 35.3 \u00b1 2.0 mL/min per 1.73 m2 for belatacept MI, belatacept LI and cyclosporine, respectively (p < 0.001"}, {"end": 1195, "start": 962, "text": "Mean ... |
In the Belatacept Evaluation of Nephroprotection and Efficacy as First‐Line Immunosuppression Trial–Extended Criteria Donors (BENEFIT‐EXT), extended criteria donor kidney recipients were randomized to receive belatacept‐based (more intense [MI] or less intense [LI]) or cyclosporine‐based immunosuppression. In prior ana... | Intervention: belatacept (more intense [MI] or less intense [LI])
Comparator: cyclosporine
Outcome: Acute rejection rates and safety profiles | 0 | {"evidence_spans": [{"end": 1534, "start": 1432, "text": "Acute rejection rates and safety profiles of belatacept\u2010 and cyclosporine\u2010based treatment were similar"}, {"end": 1535, "start": 1432, "text": "Acute rejection rates and safety profiles of belatacept\u2010 and cyclosporine\u2010based treatment were sim... |
Introduction
Luteal phase support in assisted reproductive technology (ART) cycles is still controversial. The present study was conducted to evaluate the effect of adding oral oestradiol to progesterone during ART cycles.
Material and methods
In this prospective case control study, infertile women under 35 years ... | Intervention: oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone
Comparator: the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive... | 0 | {"evidence_spans": [{"end": 8063, "start": 7877, "text": "ity (primary or secondary).\r\nThe mean duration of infertility was 5.98 \u00b10.55 years in the control group and 7.81 \u00b11.37 years in the oestradiol group, but this difference was not statisti"}, {"end": 8063, "start": 7878, "text": "ty (primary or seconda... |
Introduction
Luteal phase support in assisted reproductive technology (ART) cycles is still controversial. The present study was conducted to evaluate the effect of adding oral oestradiol to progesterone during ART cycles.
Material and methods
In this prospective case control study, infertile women under 35 years ... | Intervention: oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone
Comparator: the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive... | 0 | {"evidence_spans": [{"end": 8164, "start": 8064, "text": "ally significant (P > 0.05). There were no significant differences between the two groups in LH leve"}, {"end": 8165, "start": 8064, "text": "ally significant (P > 0.05). There were no significant differences between the two groups in LH level"}], "id": "13670",... |
Introduction
Luteal phase support in assisted reproductive technology (ART) cycles is still controversial. The present study was conducted to evaluate the effect of adding oral oestradiol to progesterone during ART cycles.
Material and methods
In this prospective case control study, infertile women under 35 years ... | Intervention: oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone
Comparator: the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive... | 0 | {"evidence_spans": [{"end": 1406, "start": 1194, "text": "roups. Although the serum progesterone concentration was higher in the oestradiol group in comparison to the control group on day 7, 10 and 12 after embryo transfer, these differences were not statistically signi"}, {"end": 8382, "start": 8166, "text": " measure... |
Introduction
Luteal phase support in assisted reproductive technology (ART) cycles is still controversial. The present study was conducted to evaluate the effect of adding oral oestradiol to progesterone during ART cycles.
Material and methods
In this prospective case control study, infertile women under 35 years ... | Intervention: oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone
Comparator: the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive... | 0 | {"evidence_spans": [{"end": 1193, "start": 1019, "text": "= 51). There were no significant differences in the mean number of retrieved oocytes, number of transferred embryos, or chemical and clinical pregnancy rates between the two "}, {"end": 8556, "start": 8382, "text": "ficant (P > 0.05) (Table II). The mean number ... |
Context:
Dentinal hypersensitivity (DH) is a chronic disorder in which patients report sharp and acute pain to a variety of stimuli. Till date, a standardized procedure to treat DH is missing, though several alternative treatment strategies have been designed, including laser therapies.
Aim:
The aim of the study w... | Intervention: combined 5% KNO3 and the diode laser
Comparator: 1-5% potassium nitrate (KNO3)
Outcome: Dentinal hypersensitivity (DH) | -1 | {"evidence_spans": [{"end": 1053, "start": 966, "text": "Results:\r\nSynergistic use of 5% KNO3 and diode laser (Group 3) significantly reduced th"}, {"end": 9116, "start": 8974, "text": " in VAS scores between the groups at baseline. A significant reduction in DH was observed for Group 3 (GaAlA laser diode and 5% KNO3... |
Context:
Dentinal hypersensitivity (DH) is a chronic disorder in which patients report sharp and acute pain to a variety of stimuli. Till date, a standardized procedure to treat DH is missing, though several alternative treatment strategies have been designed, including laser therapies.
Aim:
The aim of the study w... | Intervention: gallium-aluminum-arsenide diode laser
Comparator: 1-5% potassium nitrate (KNO3)
Outcome: Dentinal hypersensitivity (DH) | -1 | {"evidence_spans": [{"end": 9116, "start": 8974, "text": " in VAS scores between the groups at baseline. A significant reduction in DH was observed for Group 3 (GaAlA laser diode and 5% KNO3) and Grou"}], "id": "13674", "pmcid": "5827507", "prompt_id": "13674", "split_group_id": "5827507", "votes": {"-1": 1}} |
Background
Few studies have documented the possibility of treatment-induced improvements in language functions 12 months or longer after stroke. The purpose of the current study was to provide a preliminary estimate of efficacy of constraint-induced aphasia therapy (CIAT) when compared to no-intervention in patients w... | Intervention: constraint-induced aphasia therapy (CIAT)
Comparator: no intervention
Outcome: mini-Communicative Abilities Log (mini-CAL) score at 12 weeks | 1 | {"evidence_spans": [{"end": 1537, "start": 1402, "text": "lities. At 12 weeks, the treatment group reported better subjective communication abilities (mini-CAL) than the no-intervention group ("}, {"end": 16034, "start": 15857, "text": "mmunication abilities assessed with the mini-CAL. Patients who received CIAT scored... |
Background
Few studies have documented the possibility of treatment-induced improvements in language functions 12 months or longer after stroke. The purpose of the current study was to provide a preliminary estimate of efficacy of constraint-induced aphasia therapy (CIAT) when compared to no-intervention in patients w... | Intervention: constraint-induced aphasia therapy (CIAT)
Comparator: no intervention
Outcome: the Semantic Fluency Test (SFT) score | 0 | {"evidence_spans": [{"end": 16255, "start": 16036, "text": ". 23; difference=8, 95% CI 1.3 to 13.5, p=0.019). The SFT was marginally higher 2 weeks after intervention in CIAT patients than controls (Mean 21 vs. 12; difference 9, 95% CI \u22120.3 to 17.8, p=0.058). This difference was"}], "id": "13676", "pmcid": "458867... |
Recently, the intestinal microbiota has been emphasised as an important contributor to the development of metabolic syndrome. Dietary fibre may exert beneficial effects through modulation of the intestinal microbiota and metabolic end products. We investigated the effects of a diet enriched with two different dietary f... | Intervention: low-fibre Western-style diet (WSD)
Comparator: healthy-carbohydrate diet (HCD)
Outcome: faecal consistency | 1 | {"evidence_spans": [{"end": 23889, "start": 23640, "text": "nergy needs, respectively. The subjects\u2019 body weights, waist circumferences and body fat percentages remained unchanged throughout the study (S2 Table).\r\n\r\nFaecal characteristics and gastrointestinal symptoms\r\nBowel movements over the three-day regi... |
Recently, the intestinal microbiota has been emphasised as an important contributor to the development of metabolic syndrome. Dietary fibre may exert beneficial effects through modulation of the intestinal microbiota and metabolic end products. We investigated the effects of a diet enriched with two different dietary f... | Intervention: healthy-carbohydrate diet (HCD)
Comparator: low-fibre Western-style diet (WSD)
Outcome: number of observed species (alpha-diversity) in the stools | -1 | {"evidence_spans": [{"end": 27182, "start": 26972, "text": "alysis and therefore, 95% CI are given.\r\n\r\nFaecal microbial composition\r\n16S rRNA gene amplicon sequencing was performed to identify the microbial compositions in faecal samples collected at baseline and at the"}], "id": "13678", "pmcid": "4951149", "pro... |
Summary
Background
Until now there has been no study that directly compares the effect of lansoprazole and pantoprazole administered intravenously on intragastric acidity. The aim of this study is to compare the effect of lansoprazole (30 mg) and pantoprazole (40 mg) administered intravenously on gastric acidity.
... | Intervention: Lansoprazole 30 mg intravenously
Comparator: pantoprazole 40 mg intravenously
Outcome: The mean time for pH >4 and pH >6 | 0 | {"evidence_spans": [{"end": 12876, "start": 12605, "text": "ing the first 4 hours, on day 1 and pH >6 on day 5.\r\nThe mean time for pH >4 and pH >6 with lansoprazole was shorter than with pantoprazole on day 1, but the difference was not statistically significant (109.61\u00b132.15 min vs. 153.42\u00b129.36 min, P=0.3... |
Objective
We aimed to evaluate whether preoperative chemotherapy provides benefits in the survival and prognosis of patients with non-small cell lung cancer (NSCLC) in resectable stages I to IIIA, except T1N0.
Methods
In this randomized, controlled trial, 356 patients with stage I (except for T1N0), II and IIIA NS... | Intervention: preoperative chemotherapy plus surgery
Comparator: surgery-alone arm
Outcome: The median survival time (MST) for patients with non-small cell lung cancer (NSCLC) | -1 | {"evidence_spans": [{"end": 950, "start": 793, "text": "owever, the median survival time (MST) in the preoperative chemotherapy arm was lower than that of surgery-alone arm (MST, 45.42 months vs 57.59 months) (P ="}, {"end": 9477, "start": 9282, "text": "vely in the surgery-alone arm (Figure 2). The median survival tim... |
Objective
We aimed to evaluate whether preoperative chemotherapy provides benefits in the survival and prognosis of patients with non-small cell lung cancer (NSCLC) in resectable stages I to IIIA, except T1N0.
Methods
In this randomized, controlled trial, 356 patients with stage I (except for T1N0), II and IIIA NS... | Intervention: preoperative chemotherapy plus surgery
Comparator: surgery-alone arm
Outcome: The MST of stage II non-small cell lung cancer (NSCLC) | -1 | {"evidence_spans": [{"end": 951, "start": 795, "text": "ever, the median survival time (MST) in the preoperative chemotherapy arm was lower than that of surgery-alone arm (MST, 45.42 months vs 57.59 months) (P = "}, {"end": 10004, "start": 9859, "text": " respectively in the primary surgery arm. The MST of stage II NSC... |
Objective
We aimed to evaluate whether preoperative chemotherapy provides benefits in the survival and prognosis of patients with non-small cell lung cancer (NSCLC) in resectable stages I to IIIA, except T1N0.
Methods
In this randomized, controlled trial, 356 patients with stage I (except for T1N0), II and IIIA NS... | Intervention: preoperative chemotherapy plus surgery
Comparator: surgery-alone arm
Outcome: survival rates of stage I and stage IIIA non-small cell lung cancer (NSCLC) | 0 | {"evidence_spans": [{"end": 10173, "start": 10005, "text": "primary surgery arm (log-rank P = 0.044). There were not significant differences between the two arms in the survival rates of stage I and stage IIIA NSCLC (log-rank P "}, {"end": 10175, "start": 10006, "text": "rimary surgery arm (log-rank P = 0.044). There w... |
Objective
We aimed to evaluate whether preoperative chemotherapy provides benefits in the survival and prognosis of patients with non-small cell lung cancer (NSCLC) in resectable stages I to IIIA, except T1N0.
Methods
In this randomized, controlled trial, 356 patients with stage I (except for T1N0), II and IIIA NS... | Intervention: preoperative chemotherapy plus surgery
Comparator: surgery-alone arm
Outcome: Progression-free survival for patients with non-small cell lung cancer (NSCLC) | 0 | {"evidence_spans": [{"end": 10460, "start": 10203, "text": "espectively).\r\n\r\nProgression-free survival\r\nNo statistical difference in PFS was seen between the two arms, with a HR of progression of 1.135 (95% CI, 0.855\u20131.506). The median PFS time was 42.21 months in the preoperative chemotherapy arm and 45.67 ... |
Background
We hypothesized that acutely sleep-deprived participants would rate ascending concentrations of sucrose as more intense and pleasant, than they would do after one night of normal sleep. Such a finding would offer a potential mechanism through which acute sleep loss could promote overeating in humans.
Met... | Intervention: total sleep deprivation (TSD) + six yogurt probes with varying sucrose concentrations (2–29 %)
Comparator: sleep (permitted between 22:30 and 06:30 h)+ six orally presented yogurt probes with varying sucrose concentrations (2–29 %)
Outcome: hunger | 0 | {"evidence_spans": [{"end": 1128, "start": 1035, "text": "trast, the change in hunger induced by the preload was similar between the sleep and TSD cond"}, {"end": 8811, "start": 8584, "text": ".e., 20\u00a0min after the preload]). However, no significant differences between the TSD and sleep conditions were observed wh... |
Background
We hypothesized that acutely sleep-deprived participants would rate ascending concentrations of sucrose as more intense and pleasant, than they would do after one night of normal sleep. Such a finding would offer a potential mechanism through which acute sleep loss could promote overeating in humans.
Met... | Intervention: total sleep deprivation (TSD) + six yogurt probes with varying sucrose concentrations (2–29 %)
Comparator: sleep (permitted between 22:30 and 06:30&nbsp;h)+ six orally presented yogurt probes with varying sucrose concentrations (2–29 %)
Outcome: ratings of sweet intensity or pleasantness of the yogur... | 0 | {"evidence_spans": [{"end": 9795, "start": 9589, "text": " deprivation (solid line) conditions. As indicated by repeated measures ANOVA, ratings of sweet intensity or pleasantness of the yogurt samples with varying sucrose concentrations did not significantly (i.e"}, {"end": 9796, "start": 9631, "text": "ndicated by re... |
Background
We hypothesized that acutely sleep-deprived participants would rate ascending concentrations of sucrose as more intense and pleasant, than they would do after one night of normal sleep. Such a finding would offer a potential mechanism through which acute sleep loss could promote overeating in humans.
Met... | Intervention: total sleep deprivation (TSD) + six yogurt probes with varying sucrose concentrations (2–29 %)
Comparator: sleep (permitted between 22:30 and 06:30&amp;nbsp;h)+ six orally presented yogurt probes with varying sucrose concentrations (2–29 %)
Outcome: Plasma glucose measurements | 0 | {"evidence_spans": [{"end": 1274, "start": 1129, "text": "tions. Plasma concentrations of ghrelin were significantly higher under conditions of TSD, whereas plasma glucose did not differ between the cond"}, {"end": 10584, "start": 10457, "text": "l sleep time/time in bed.\r\n\r\nGlucose and hormonal measurements\r\nPla... |
Background
We hypothesized that acutely sleep-deprived participants would rate ascending concentrations of sucrose as more intense and pleasant, than they would do after one night of normal sleep. Such a finding would offer a potential mechanism through which acute sleep loss could promote overeating in humans.
Met... | Intervention: total sleep deprivation (TSD) + six yogurt probes with varying sucrose concentrations (2–29 %)
Comparator: sleep (permitted between 22:30 and 06:30&amp;amp;nbsp;h)+ six orally presented yogurt probes with varying sucrose concentrations (2–29 %)
Outcome: Plasma concentrations of total ghrelin | 1 | {"evidence_spans": [{"end": 1211, "start": 1129, "text": "tions. Plasma concentrations of ghrelin were significantly higher under conditions"}, {"end": 10729, "start": 10585, "text": "leep conditions (TSD vs Sleep, 5.4\u2009\u00b1\u20090.5 vs. 5.3\u2009\u00b1\u20090.4\u00a0mmol/l). Plasma concentrations of total ghreli... |
Background and objectives
This controlled single-blind trial compared the efficacy of a lip balm with propolis special extract GH 2002 at a concentration of 0.5% in the treatment of episodes of herpes labialis with that of 5% aciclovir cream.
Methods
Patients in the erythematous/papular stage were randomized: 189 ... | Intervention: lip balm with propolis special extract GH 2002
Comparator: lip balm with aciclovir cream
Outcome: The median time to complete encrustation/epithelialization | -1 | {"evidence_spans": [{"end": 15988, "start": 15661, "text": "f a difference between groups of 0.5 days in favor of propolis. The median time to complete encrustation/epithelialization was 4.0 days with propolis (average 4.41 [1.63] days), and 5.0 days with aciclovir (average 5.54 [1.87]). The superiority of propolis was... |
Background and objectives
This controlled single-blind trial compared the efficacy of a lip balm with propolis special extract GH 2002 at a concentration of 0.5% in the treatment of episodes of herpes labialis with that of 5% aciclovir cream.
Methods
Patients in the erythematous/papular stage were randomized: 189 ... | Intervention: lip balm with propolis special extract GH 2002
Comparator: lip balm with aciclovir cream
Outcome: severe tension and swelling | -1 | {"evidence_spans": [{"end": 17598, "start": 17421, "text": "o statistically significant difference between groups (ITT population). Overall, patients in the aciclovir group had more severe tension and swelling than patients in the group "}], "id": "13690", "pmcid": "5737953", "prompt_id": "13690", "split_group_id": "57... |
Background and objectives
This controlled single-blind trial compared the efficacy of a lip balm with propolis special extract GH 2002 at a concentration of 0.5% in the treatment of episodes of herpes labialis with that of 5% aciclovir cream.
Methods
Patients in the erythematous/papular stage were randomized: 189 ... | Intervention: lip balm with propolis special extract GH 2002
Comparator: lip balm with aciclovir cream
Outcome: itching or burning | -1 | {"evidence_spans": [{"end": 17896, "start": 17599, "text": "sing propolis (P = 0.042 based on Mann-Whitney U test; data not shown).\r\nFor the further visits on Days 2 to 5 there was a significant difference in favor of propolis, reaching 89% versus 66% free of itching or burning (Figure 6), and 94% versus 74% free of ... |
Background and objectives
This controlled single-blind trial compared the efficacy of a lip balm with propolis special extract GH 2002 at a concentration of 0.5% in the treatment of episodes of herpes labialis with that of 5% aciclovir cream.
Methods
Patients in the erythematous/papular stage were randomized: 189 ... | Intervention: lip balm with propolis special extract GH 2002
Comparator: lip balm with aciclovir cream
Outcome: assessment of global efficacy by the physicians "good" to "very good"" | 1 | {"evidence_spans": [{"end": 18624, "start": 18427, "text": "ssment of global efficacy by the physicians (Figure 8). At the visit on Day 5, 94.7% of patients treated with propolis and 68.4% of patients treated with aciclovir received efficacy assessments of "}, {"end": 18871, "start": 18569, "text": "reated with aciclov... |
Aims
Lobeglitazone has been developed for the treatment of type 2 diabetes mellitus. This study was conducted to evaluate potential drug–drug interactions between lobeglitazone and warfarin, an anticoagulant with a narrow therapeutic index.
Methods
In this open-label, three-treatment, crossover study, 24 healthy m... | Intervention: lobeglitazone (0.5 mg) for 1–12 days with warfarin (25 mg)
Comparator: warfarin (25 mg) alone
Outcome: findings for vital signs or physical examination results | 0 | {"evidence_spans": [{"end": 14042, "start": 13946, "text": "lue was <2.0 and who recovered without any medication. No clinically significant findings for vi"}, {"end": 14044, "start": 13947, "text": "ue was <2.0 and who recovered without any medication. No clinically significant findings for vita"}], "id": "13694", "pm... |
Background
Although cisatracurium has many advantages in anesthetic practices, the best choice of a nondepolarizing neuromuscular blocking agent that can replace succinylcholine is rocuronium. However, it is reported that remifentanil with propofol might provide reliable intubating condition, even without a neuromuscu... | Intervention: Rocuronium 0.9 mg/kg (R group)
Comparator: cisatracurium 0.15 mg/kg (C group)
Outcome: The best time to laryngoscopy | -1 | {"evidence_spans": [{"end": 1538, "start": 1358, "text": "sults\r\nThe best time to laryngoscopy was predicted by measuring TOF and was found to be significantly longer in the C group (197 \u00b1 53 s) than in the R group (102 \u00b1 49 s) (P value <"}], "id": "13695", "pmcid": "3558647", "prompt_id": "13695", "split_g... |
Background
The present study sought to determine if subjects who had consumed coffee before performing a simulated computer office-work task found to provoke pain in the neck and shoulders and forearms and wrists exhibited different time course in the pain development than the subjects who had abstained from coffee in... | Intervention: coffee (1/2 -1 cup) on average 1 h 18 min before start
Comparator: abstained from coffee intake
Outcome: The pain level in the active side of the shoulder/neck | -1 | {"evidence_spans": [{"end": 6265, "start": 6135, "text": "uring the work task (Figure 1). The pain increase in the active side of the shoulder/neck was significantly lower for the coffee c"}, {"end": 6284, "start": 6135, "text": "uring the work task (Figure 1). The pain increase in the active side of the shoulder/neck ... |
Background
Increasing numbers of students use stimulants such as methylphenidate (MPH) to improve their study capacity, making them prone to subsequent prolonged drug abuse. This study explored the cognitive effects of MPH in students who either assumed they received MPH or assumed they received a placebo.
Methods
... | Intervention: methylphenidate (MPH) 20 mg
Comparator: placebo
Outcome: recalled the last five words | 0 | {"evidence_spans": [{"end": 18599, "start": 18384, "text": "ere still in short-term memory (Table 3). All applicable P-values were significant. In general, subjects who reported a treatment assumption of MPH or DNK recalled the last five words better than those who assumed p"}, {"end": 18599, "start": 18525, "text": "o... |
Background
Increasing numbers of students use stimulants such as methylphenidate (MPH) to improve their study capacity, making them prone to subsequent prolonged drug abuse. This study explored the cognitive effects of MPH in students who either assumed they received MPH or assumed they received a placebo.
Methods
... | Intervention: methylphenidate (MPH) 20 mg
Comparator: placebo
Outcome: anger and fatigue | 1 | {"evidence_spans": [{"end": 20855, "start": 20683, "text": "ses\r\nThe POMS results showed an alteration in subjective mood the day after administration. Participants whose treatment assumption after final free recall was MPH showed s"}], "id": "13698", "pmcid": "3770494", "prompt_id": "13698", "split_group_id": "37704... |
Introduction
Glucose measurement in intensive care medicine is performed intermittently with the risk of undetected hypoglycemia. The workload for the ICU nursing staff is substantial. Subcutaneous continuous glucose monitoring (CGM) systems are available and may be able to solve some of these issues in critically ill... | Intervention: intervention group these data were used to feed a computerized glucose regulation algorithm
Comparator: continuous glucose monitoring (CGM) data were blinded in the control group
Outcome: daily nursing workload for glucose control | -1 | {"evidence_spans": [{"end": 1529, "start": 1390, "text": "roups. A significant reduction in daily nursing workload for glucose control was found in the intervention group (17 versus 36\u00a0minutes; P <"}, {"end": 1528, "start": 1391, "text": "oups. A significant reduction in daily nursing workload for glucose control ... |
Introduction
Glucose measurement in intensive care medicine is performed intermittently with the risk of undetected hypoglycemia. The workload for the ICU nursing staff is substantial. Subcutaneous continuous glucose monitoring (CGM) systems are available and may be able to solve some of these issues in critically ill... | Intervention: intervention group these data were used to feed a computerized glucose regulation algorithm
Comparator: continuous glucose monitoring (CGM) data were blinded in the control group
Outcome: Mean daily costs per patient | -1 | {"evidence_spans": [{"end": 1653, "start": 1529, "text": "0.001). Mean daily costs per patient were significantly reduced with EUR 12 (95% CI \u221232 to \u221218, P\u2009=\u20090.02) in the interventio"}, {"end": 1654, "start": 1530, "text": ".001). Mean daily costs per patient were significantly reduced with EUR 12 (... |
Objectives
This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (≥2 months) use of tiotropium HandiHaler 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients who switched from H... | Intervention: Respimat 2.5 µg (R 2.5), Respimat 5 µg(R5)
Comparator: HandiHaler 18 µg (HH18)
Outcome: incidence of cardiac disorders | -1 | {"evidence_spans": [{"end": 18064, "start": 17811, "text": "s lower in the Respimat 5\u2005\u00b5g versus the HandiHaler group (HR 0.62; 95% CI 0.43 to 0.89; Respimat 2.5\u2005\u00b5g: HR 0.78; 95% CI 0.55 to 1.09) (see E-figure 1). Causes of death were similar across the treatment groups, including death from cardiac ... |
Objectives
This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (≥2 months) use of tiotropium HandiHaler 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients who switched from H... | Intervention: Respimat 2.5 µg (R 2.5), Respimat 5 µg(R5)
Comparator: HandiHaler 18 µg (HH18)
Outcome: number of cardiac deaths | 0 | {"evidence_spans": [{"end": 18064, "start": 17811, "text": "s lower in the Respimat 5\u2005\u00b5g versus the HandiHaler group (HR 0.62; 95% CI 0.43 to 0.89; Respimat 2.5\u2005\u00b5g: HR 0.78; 95% CI 0.55 to 1.09) (see E-figure 1). Causes of death were similar across the treatment groups, including death from cardiac ... |
Objectives
This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (≥2 months) use of tiotropium HandiHaler 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients who switched from H... | Intervention: Respimat 2.5 µg (R 2.5), Respimat 5 µg(R5)
Comparator: HandiHaler 18 µg (HH18)
Outcome: cardiac arrhythmia or cardiac history defined as history of MI, ischaemic heart disease/coronary artery disease, cardiac arrhythmia or heart failure | 0 | {"evidence_spans": [{"end": 21111, "start": 20628, "text": "nic obstructive pulmonary disease; MACE, major adverse cardiovascular event (stroke, transient ischaemic attack, myocardial infarction, sudden death, cardiac death, sudden cardiac death or fatal event in the system organ classes for cardiac and vascular disord... |
Objectives
This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (≥2 months) use of tiotropium HandiHaler 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients who switched from H... | Intervention: Respimat 2.5 µg (R 2.5), Respimat 5 µg(R5)
Comparator: HandiHaler 18 µg (HH18)
Outcome: safety,The risk of exacerbation and major adverse cardiovascular (CV) events (MACEs) | 0 | {"evidence_spans": [{"end": 1609, "start": 1159, "text": " in all groups. Respimat had a similar mortality risk versus HH18 (vital status follow-up, HR; 95% CI R2.5: 0.87; 0.64 to 1.17; R5: 0.79; 0.58 to 1.07) with no significant differences in the risk and rates of exacerbations and severe exacerbations across treatme... |
OBJECTIVE
To evaluate the effects of insulin glargine and n-3 polyunsaturated fatty acid (n-3FA) supplements on carotid intima-media thickness (CIMT).
RESEARCH DESIGN AND METHODS
We enrolled 1,184 people with cardiovascular (CV) disease and/or CV risk factors plus impaired fasting glucose, impaired glucose toleran... | Intervention: insulin glargine and n-3 polyunsaturated fatty acid (n-3FA) supplements
Comparator: standard glycemic care and double-blind therapy with a 1-g capsule of n-3FA;
Outcome: carotid intima-media thickness (CIMT) | 0 | {"evidence_spans": [{"end": 1187, "start": 1005, "text": "SULTS\r\nCompared with standard care, insulin glargine reduced the primary CIMT outcome, but the difference was not statistically significant (difference = 0.0030 \u00b1 0.0021 mm/year; P ="}, {"end": 1462, "start": 1005, "text": "SULTS\r\nCompared with standard... |
OBJECTIVE
To evaluate the effects of insulin glargine and n-3 polyunsaturated fatty acid (n-3FA) supplements on carotid intima-media thickness (CIMT).
RESEARCH DESIGN AND METHODS
We enrolled 1,184 people with cardiovascular (CV) disease and/or CV risk factors plus impaired fasting glucose, impaired glucose toleran... | Intervention: insulin glargine and n-3 polyunsaturated fatty acid (n-3FA) supplements
Comparator: placebo
Outcome: carotid intima-media thickness (CIMT), change in maximum CIMT for the common carotid and the common carotid plus bifurcation | 0 | {"evidence_spans": [{"end": 1462, "start": 1350, "text": "vely). There were no differences in the primary and secondary outcomes between the n-3FA supplement and placebo "}], "id": "13707", "pmcid": "3747889", "prompt_id": "13707", "split_group_id": "3747889", "votes": {"0": 2}} |
Background
The Quality of Recovery-15 (QoR-15) is a patient-centered questionnaire to evaluate the recovery after surgery and anesthesia. Dexmedetomidine has sedative, analgesic, antiinflammatory and inhibitory sympathetic effects, which may contribute to early recovery. We hypothesized dexmedetomidine added to intrav... | Intervention: group D received dexmedetomidine 0.04 ug/(kg·h) plus sufentanil 0.02 ug/(kg·h)
Comparator: control group S received sufentanil 0.04 ug/(kg·h)
Outcome: quality of recovery (QoR) | 1 | {"evidence_spans": [{"end": 1141, "start": 1010, "text": "sults\r\nThe QoR-15 scores were significantly higher in the group D than in the group S on postoperative day (POD) 1, 2, 3 and 5 (P <"}], "id": "13711", "pmcid": "5725027", "prompt_id": "13711", "split_group_id": "5725027", "votes": {"1": 2}} |
Background
The Quality of Recovery-15 (QoR-15) is a patient-centered questionnaire to evaluate the recovery after surgery and anesthesia. Dexmedetomidine has sedative, analgesic, antiinflammatory and inhibitory sympathetic effects, which may contribute to early recovery. We hypothesized dexmedetomidine added to intrav... | Intervention: group D received dexmedetomidine 0.04 ug/(kg·h) plus sufentanil 0.02 ug/(kg·h)
Comparator: control group S received sufentanil 0.04 ug/(kg·h)
Outcome: The pressing times of analgesic pump and rescue tramadol | 0 | {"evidence_spans": [{"end": 1403, "start": 1279, "text": "0.05). The pressing times of analgesic pump and rescue tramadol were not significantly different between the two groups (P >"}], "id": "13712", "pmcid": "5725027", "prompt_id": "13712", "split_group_id": "5725027", "votes": {"0": 2}} |
Background
The Quality of Recovery-15 (QoR-15) is a patient-centered questionnaire to evaluate the recovery after surgery and anesthesia. Dexmedetomidine has sedative, analgesic, antiinflammatory and inhibitory sympathetic effects, which may contribute to early recovery. We hypothesized dexmedetomidine added to intrav... | Intervention: group D received dexmedetomidine 0.04 ug/(kg·h) plus sufentanil 0.02 ug/(kg·h)
Comparator: control group S received sufentanil 0.04 ug/(kg·h)
Outcome: incidence of nausea | -1 | {"evidence_spans": [{"end": 1467, "start": 1404, "text": "0.05). The incidence of nausea was significantly lower in the G"}, {"end": 11605, "start": 11516, "text": "p D were higher than that of group S (p < 0.05).\r\nFigure 4Results of time to first flatus"}], "id": "13713", "pmcid": "5725027", "prompt_id": "13713", "s... |
Background
The Quality of Recovery-15 (QoR-15) is a patient-centered questionnaire to evaluate the recovery after surgery and anesthesia. Dexmedetomidine has sedative, analgesic, antiinflammatory and inhibitory sympathetic effects, which may contribute to early recovery. We hypothesized dexmedetomidine added to intrav... | Intervention: group D received dexmedetomidine 0.04 ug/(kg·h) plus sufentanil 0.02 ug/(kg·h)
Comparator: control group S received sufentanil 0.04 ug/(kg·h)
Outcome: Vomiting | 0 | {"evidence_spans": [{"end": 8129, "start": 8030, "text": "operation, POD1, POD2, POD3, POD5 and POD7\r\nAbbreviation: POD, postoperative day. ** P < 0.01, grou"}, {"end": 11605, "start": 11395, "text": "tus after surgery was shorter in the group D than in the group S (p < 0.05; Figure 4). The scores of satisfaction of ... |
Purpose
A randomized, controlled trial comparing hand-assisted laparoscopic restorative proctocolectomy with open surgery did not show an advantage for the laparoscopic approach. The trial was criticized because hand-assisted laparoscopic restorative proctocolectomy was not considered a true laparoscopic proctocolecto... | Intervention: total laparoscopic restorative proctocolectomy
Comparator: hand-assisted laparoscopic restorative proctocolectomy and open restorative proctocolectomy
Outcome: Median operating time | -1 | {"evidence_spans": [{"end": 1620, "start": 1432, "text": ".001). Morbidity and reoperation rates in the total laparoscopic, hand-assisted laparoscopic, and open groups were comparable (29 vs. 20 vs. 23 percent and 17 vs.10 vs. 13 percent, respect"}], "id": "13715", "pmcid": "2365983", "prompt_id": "13715", "split_group... |
Purpose
A randomized, controlled trial comparing hand-assisted laparoscopic restorative proctocolectomy with open surgery did not show an advantage for the laparoscopic approach. The trial was criticized because hand-assisted laparoscopic restorative proctocolectomy was not considered a true laparoscopic proctocolecto... | Intervention: total laparoscopic restorative proctocolectomy
Comparator: hand-assisted laparoscopic restorative proctocolectomy, and open restorative proctocolectomy
Outcome: Morbidity and reoperation rates | 0 | {"evidence_spans": [{"end": 1618, "start": 1431, "text": "0.001). Morbidity and reoperation rates in the total laparoscopic, hand-assisted laparoscopic, and open groups were comparable (29 vs. 20 vs. 23 percent and 17 vs.10 vs. 13 percent, respe"}], "id": "13716", "pmcid": "2365983", "prompt_id": "13716", "split_group_... |
Purpose
A randomized, controlled trial comparing hand-assisted laparoscopic restorative proctocolectomy with open surgery did not show an advantage for the laparoscopic approach. The trial was criticized because hand-assisted laparoscopic restorative proctocolectomy was not considered a true laparoscopic proctocolecto... | Intervention: total laparoscopic restorative proctocolectomy
Comparator: hand-assisted laparoscopic restorative proctocolectomy and open restorative proctocolectomy
Outcome: daily and total morphine requirement | -1 | {"evidence_spans": [{"end": 15383, "start": 15215, "text": "days in the TLRP, HAL-RP, and ORP groups, respectively; P\u2009=\u20090.004 and P\u2009=\u20090.018, respectively). In spite of this, there was no statistical difference in hospital stay b"}], "id": "13717", "pmcid": "2365983", "prompt_id": "13717", "split_gro... |
Purpose
A randomized, controlled trial comparing hand-assisted laparoscopic restorative proctocolectomy with open surgery did not show an advantage for the laparoscopic approach. The trial was criticized because hand-assisted laparoscopic restorative proctocolectomy was not considered a true laparoscopic proctocolecto... | Intervention: total laparoscopic restorative proctocolectomy
Comparator: hand-assisted laparoscopic restorative proctocolectomy
Outcome: costs | 0 | {"evidence_spans": [{"end": 1861, "start": 1800, "text": "cant). There were no differences in quality of life and total"}, {"end": 17550, "start": 17343, "text": "ication of costs is shown in Table\u00a03. Costs for surgery were significantly higher in the TLRP group compared with both other groups, both because of the... |
Genetic disorders are a leading cause of morbidity and mortality in infants in neonatal and pediatric intensive care units (NICU/PICU). While genomic sequencing is useful for genetic disease diagnosis, results are usually reported too late to guide inpatient management. We performed an investigator-initiated, partially... | Intervention: rWGS plus standard genetic tests
Comparator: standard genetic tests alone
Outcome: the rate of genetic diagnosis within 28 days | 1 | {"evidence_spans": [{"end": 1408, "start": 1165, "text": "Nevertheless, intention to treat analysis showed the rate of genetic diagnosis within 28 days of enrollment (the primary end-point) to be higher in cases (31%, 10 of 32) than controls (3%, 1 of 33; difference, 28% [95% CI, 10\u201346%]; p\u2009=\u20090.003)."}, ... |
Genetic disorders are a leading cause of morbidity and mortality in infants in neonatal and pediatric intensive care units (NICU/PICU). While genomic sequencing is useful for genetic disease diagnosis, results are usually reported too late to guide inpatient management. We performed an investigator-initiated, partially... | Intervention: rWGS plus standard genetic tests
Comparator: standard genetic tests alone
Outcome: the rate of neonatal diagnosis | 1 | {"evidence_spans": [{"end": 1599, "start": 1408, "text": " Among infants enrolled in the first 25 days of life, the rate of neonatal diagnosis was higher in cases (32%, 7 of 22) than controls (0%, 0 of 23; difference, 32% [95% CI, 11\u201353%];p\u2009=\u20090.004)"}, {"end": 1600, "start": 1409, "text": "Among infants ... |
Genetic disorders are a leading cause of morbidity and mortality in infants in neonatal and pediatric intensive care units (NICU/PICU). While genomic sequencing is useful for genetic disease diagnosis, results are usually reported too late to guide inpatient management. We performed an investigator-initiated, partially... | Intervention: rWGS plus standard genetic tests
Comparator: standard genetic tests alone
Outcome: Median age at diagnosis and median time to diagnosis | -1 | {"evidence_spans": [{"end": 1857, "start": 1600, "text": " Median age at diagnosis (25 days [range 14\u201390] in cases vs. 130 days [range 37\u2013451] in controls) and median time to diagnosis (13 days [range 1\u201384] in cases, vs. 107 days [range 21\u2013429] in controls) were significantly less in cases than cont... |
Background
Patient recruitment into clinical trials is a major challenge, and the elderly, socially deprived and those with multiple comorbidities are often underrepresented. The idea of paying patients an incentive to participate in research is controversial, and evidence is needed to evaluate this as a recruitment s... | Intervention: trial invitation letter containing an incentive offer of £100
Comparator: standard trial invitation letter
Outcome: positive response to the first invitation letter | 1 | {"evidence_spans": [{"end": 1119, "start": 984, "text": "sults\r\nThe \u00a3100 incentive offer increased positive response to the first invitation letter from 24.7% to 31.6%, an increase of 6.9% (P\u2009"}, {"end": 1120, "start": 984, "text": "sults\r\nThe \u00a3100 incentive offer increased positive response to the f... |
Psychiatric symptoms and stress are on the increase among Swedish adolescents. We aimed to study the potential effect and feasibility of two Internet-based self-help programmes, one mindfulness based (iMBI) and the other music based in a randomised controlled trial that targeted adolescents. A total of 283 upper second... | Intervention: Music therapy intervention (iMT)
Comparator: The iMBI (In Swedish: Mindfulness Grundkurs 2.0 from Mindfulnesscenter AB, Sweden)
Outcome: GSI from Symptoms Checklist-90 or PSS Perceived Stress Scale-14 or PSQI Pittsburgh Sleep Quality Index | 0 | {"evidence_spans": [{"end": 22028, "start": 21695, "text": "nternet-based music therapy, and WL waiting list\r\n\r\n\r\nTable\u00a01 shows the comparisons between those who logged in and completed at least one session and those who did not log into the self-help programmes. No significant difference in any of the scale... |
Objective
This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).
Methods
ACS patients scheduled to undergo PCI (n = 130) were ... | Intervention: Danhong injection combined with Naoxintong capsule for 12 weeks
Comparator: placebo
Outcome: Circulating nitric oxide levels | 1 | {"evidence_spans": [{"end": 1149, "start": 935, "text": "group. The treatment group demonstrated better signs of clinical efficacy, including left ventricular ejection fraction, higher nitric oxide levels, and lower levels of endothelin-1 (ET-1) and von Willebrand factor"}, {"end": 20787, "start": 20602, "text": " the ... |
Objective
This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).
Methods
ACS patients scheduled to undergo PCI (n = 130) were ... | Intervention: Danhong injection combined with Naoxintong capsule for 12 weeks
Comparator: placebo
Outcome: Circulating levels of endothelin-1 (ET-1) and von Willebrand factor (VWF) | 1 | {"evidence_spans": [{"end": 21518, "start": 21169, "text": "ent and control groups were similar (P > 0.05; Table 3). At 7 days of treatment, the levels of ET-1 and VWF had decreased in both groups, but the change in the treatment group from baseline was less than that of the control group. At 12 weeks of treatment, the... |
Objective
This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).
Methods
ACS patients scheduled to undergo PCI (n = 130) were ... | Intervention: Danhong injection combined with Naoxintong capsule for 12 weeks
Comparator: placebo
Outcome: left ventricular ejection fraction | 1 | {"evidence_spans": [{"end": 1149, "start": 935, "text": "group. The treatment group demonstrated better signs of clinical efficacy, including left ventricular ejection fraction, higher nitric oxide levels, and lower levels of endothelin-1 (ET-1) and von Willebrand factor"}, {"end": 22157, "start": 21961, "text": "LVEF ... |
Objective
This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).
Methods
ACS patients scheduled to undergo PCI (n = 130) were ... | Intervention: Danhong injection combined with Naoxintong capsule for 12 weeks
Comparator: placebo
Outcome: The overall response rate | 1 | {"evidence_spans": [{"end": 19926, "start": 19803, "text": "ated excellent, effective, and ineffective in 27, 17, and 18 patients. The overall response rate of the treatment group (86"}, {"end": 19927, "start": 19804, "text": "ted excellent, effective, and ineffective in 27, 17, and 18 patients. The overall response ra... |
Purpose
The purpose of this study was to evaluate the aqueous humor bioavailability and clinical efficacy of bromfenac 0.09% vs nepafenac on the presence of cystoid macular edema (CME) after phacoemulsification.
Material and methods
A Phase II, double-blind, masked, active-controlled, multicenter, clinical trial o... | Intervention: bromfenac 0.09% ophthalmic solution
Comparator: nepafenac 0.1%
Outcome: The central retinal thickness | 0 | {"evidence_spans": [{"end": 1329, "start": 1076, "text": "roups. The central retinal thickness did not show significant changes after treatment when compared to baseline as follows: in the bromfenac group (247.2\u00b132.9 vs 252.0\u00b124.9 \u03bcm; P=0.958) and in nepafenac group (250.8\u00b134 vs 264.0\u00b134.1 \u03... |
Abstract
Objective
To study the effectiveness of a comprehensive diabetes programme in general practice that integrates patient-centred lifestyle counselling into structured diabetes care.
Design and setting
Cluster randomised trial in general practices.
Intervention
Nurse-led structured diabetes care with a ... | Intervention: a comprehensive programme
Comparator: usual care
Outcome: diabetes outcome measures (HbA1c, blood pressure, cholesterol, BMI). | 0 | {"evidence_spans": [{"end": 14272, "start": 14067, "text": "the medical records, but again not all patient questionnaires were returned (see Figure 2). The follow-up was not affected by age or BMI, but the HbA1c of the non-responders was slightly higher (0.2%) than"}, {"end": 14272, "start": 14112, "text": "t questionn... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.